Prospector Partners LLC Makes New $4.18 Million Investment in Option Care Health, Inc. $OPCH

Prospector Partners LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 150,440 shares of the company’s stock, valued at approximately $4,176,000. Prospector Partners LLC owned about 0.09% of Option Care Health as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in OPCH. Teton Advisors Inc. raised its position in Option Care Health by 2.2% in the 2nd quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock worth $564,000 after purchasing an additional 368 shares during the period. Assetmark Inc. grew its stake in shares of Option Care Health by 1.6% during the second quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after buying an additional 416 shares during the last quarter. State of Wyoming grew its stake in shares of Option Care Health by 1.8% during the second quarter. State of Wyoming now owns 25,135 shares of the company’s stock valued at $816,000 after buying an additional 436 shares during the last quarter. Arizona State Retirement System raised its holdings in shares of Option Care Health by 1.1% in the third quarter. Arizona State Retirement System now owns 48,472 shares of the company’s stock worth $1,346,000 after buying an additional 540 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Option Care Health by 24.1% during the 3rd quarter. GAMMA Investing LLC now owns 3,093 shares of the company’s stock worth $86,000 after acquiring an additional 600 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Barrington Research upped their price objective on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. Jefferies Financial Group reissued a “buy” rating and set a $37.00 target price on shares of Option Care Health in a research note on Tuesday, January 13th. Truist Financial set a $40.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. Bank of America lifted their price objective on shares of Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Finally, Morgan Stanley boosted their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research report on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.58.

Option Care Health Stock Up 0.7%

NASDAQ:OPCH opened at $35.50 on Thursday. Option Care Health, Inc. has a 1-year low of $24.24 and a 1-year high of $36.80. The company has a 50-day moving average of $33.82 and a 200 day moving average of $30.29. The firm has a market cap of $5.63 billion, a PE ratio of 28.17, a price-to-earnings-growth ratio of 2.10 and a beta of 0.84. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.